Testosterone Cypionate vs Enanthate: complete comparison (esters, half-life, choice)
| Critère | testosterone-cypionate | testosterone-enanthate |
|---|---|---|
| Serum half-life | ~8 d (but practical profile = enanthate) | ~4.5 d |
| Serum peak | 24-48 h post-injection | 24-72 h post-injection |
| Optimal frequency | 2× per week | 2× per week |
| Vehicle oil | Cotton (US) | Sesame (EU) |
| Aromatization | Standard testo | Standard testo |
| Availability | Mostly US, Brazil | Europe, Asia |
| Relative price | Variable | Variable |
| PCT starts | ~2-3 wk after last inj | ~2-3 wk after last inj |
Quand choisir testosterone-cypionate
Choose cypionate if you are in the US or in a region where it predominates, or if you find cotton oil better tolerated than sesame (rare but happens — local irritation, injection site pain). The theoretical 8-day half-life is slightly longer than enanthate's (Schulte-Beerbühl 1980), but in clinical practice this difference is imperceptible: the serum profile with 2 injections per week overlaps almost perfectly. All pivot RCTs on testosterone (Bhasin 1996, Bhasin 2001) were conducted with enanthate, but the entirety of clinical recommendations (Bhasin 2018 - Endocrine Society) considers cypionate and enanthate as interchangeable on a mg-for-mg basis. American clinical TRT relies massively on cypionate at 100-200 mg/week, with the same documented hormonal efficacy as under European enanthate (Coviello 2008: identical erythrocyte response profile). No raw anabolic advantage: choosing cypionate is primarily a question of availability and vehicle tolerance. For bodybuilder cycles, typical dose 400-600 mg/week in 2 injections (Monday/Thursday).
Quand choisir testosterone-enanthate
Enanthate is the European standard and the subject of the widest clinical literature: Bhasin 1996, Bhasin 2001, Coviello 2008 — all historical RCTs on exogenous anabolic testosterone used enanthate. Choose it if you are in Europe or Asia (predominant availability), if you want slightly shorter kinetics allowing faster PCT timing (start at 14 days after last injection instead of 18-21 days for cypionate), or if you prefer sesame oil (sometimes better tolerated than cotton). The serum profile with 2 injections per week is smooth and well documented: peak at 24-72 h post-injection, return to baseline in ~3 weeks. Schulte-Beerbühl 1980 established the 4.5-day effective half-life that serves as basis for all modern PCT timing calculators. For TRT, typical posology 100-150 mg/week in 1 or 2 subcutaneous injections (alternative to IM with equivalent bioavailability). For bodybuilder cycle, 400-600 mg/week in 2 weekly IM injections. AI titrated on estradiol measured at W2 and W6.
Combinaison ?
No interest in combining cypionate and enanthate: it is the same active molecule, only the esters differ and the practical profile overlaps. If you have both available, choose the one you tolerate better at injection site and stay on a single ester to simplify monitoring. The only useful combination would be to compensate a temporary stock shortage: replacing 250 mg enanthate with 250 mg cypionate during a shortage week changes nothing in practical kinetics. Scheme: cypionate 250 mg Monday + enanthate 250 mg Thursday = 500 mg/week of testosterone, profile identical to 500 mg/week of single ester. Dose-dependent AI (anastrozole 0.5 mg 2× per week as routine, titrate on E2). PCT started at 3 weeks after last injection regardless of ester combination. Standard biological panel: T total, E2, hematocrit, lipids at W0, W4, W8. Sample TRT switch protocol if shortage forces ester change: simply substitute equal mg dose with no other adjustment — both esters reach steady state at the same weekly cadence. Sample cycle scheme using both: cypionate 250 mg Monday + enanthate 250 mg Thursday = 500 mg/week with peak/trough variation slightly lower than 500 mg of either single ester alone (due to slightly different absorption curves). Injection site rotation tip: alternate cotton oil days vs sesame oil days at different sites to compare local tolerance — useful diagnostic if injection site reaction is suspected. No PCT timing difference of practical significance — both esters require ~2-3 weeks wash-out before SERM start. Independent lab testing if underground product source is uncertain.
FAQ
- Cypionate or enanthate: which is more effective?
- Neither. At equivalent dose in mg of active testosterone (both release ~70-72% free testo after hydrolysis), anabolic efficacy is identical. Clinical literature (Bhasin 2018, Endocrine Society) considers both esters interchangeable for TRT and no comparative study demonstrates a bodybuilding efficacy difference. Anecdotes of 'I gained better under cypionate' are explained by real dose variations (underground vials vary in concentration) or by placebo effect.
- Why 2 injections per week and not 1?
- To stabilize serum profile. With a single weekly injection of 500 mg, the serum peak at D2 reaches 2-3× the trough at D7, creating fluctuations that translate to: peak aromatization and retention at D2-D3 (high estradiol), libido and energy trough at D6-D7 (low testosterone). With 2 injections of 250 mg (Monday/Thursday), serum coefficient of variation drops from about 50% to 15%, much more comfortable profile and better estradiol monitoring. For TRT, some even do 3× per week or daily SC injection.
- When to start PCT after enanthate vs cypionate?
- 2-3 days difference only in practice. For enanthate (half-life 4.5 d), start PCT at 14-16 days after last injection (3 half-lives + margin). For cypionate (half-life ~8 d theoretical but similar practical profile), start at 16-18 days. Standard scheme: hCG 1500 IU EOD × 10 days from PCT window onward, then clomid or nolvadex × 4-6 weeks (Rahnema 2014). T total, LH, FSH panel at W8 post-PCT.
- Does SC injection work with both esters?
- Yes, subcutaneous injection works with both testosterone esters and offers comparable bioavailability to IM (modern TRT literature supports this equivalence). SC advantages: less pain, less vascular hit risk, no need for long needle (5/8 inch enough), slower absorption that further smooths serum profile. Ideal for TRT at moderate doses (100-150 mg/week). For high bodybuilder doses (> 400 mg/week), IM in larger muscles (deltoid, vastus lateralis) remains preferred to absorb volume.
- Significant price difference?
- Not in absolute, but variable by sources. In Western pharmacy on prescription, both at generic price. On the black market, price depends on the brand (pharma vs UGL), not the ester. A 10 mL vial at 250 mg/mL typically costs 30-60 € regardless of ester. Enanthate in Europe and cypionate in US are equivalent in availability and price. Prioritize source reliability over economy.
- Can sesame oil cause allergic reaction?
- Rare but documented. Sesame allergy is increasing and can manifest as extensive erythema at injection site, pruritus, or systemic reaction in highly sensitive subjects. If suspected: switch to cypionate in cotton oil or short ester in MCT oil. Always do a skin test (1-2 mL SC before first standard IM injection) if known atopic background. Peanut oil (original Sustanon) poses more problems than sesame or cotton in terms of allergy.
- Can you switch cypionate → enanthate mid-cycle?
- Yes, without any dose adjustment. Substituting 250 mg cypionate with 250 mg enanthate produces a nearly identical serum profile. The only useful adjustment: if you switch from a single weekly cypionate injection to enanthate, increase to 2 injections per week to benefit from shorter kinetics and smooth the profile. No PCT adjustment either: the practical clearance of both esters is similar (15-18 days), and the SERM scheme remains identical.
- Hematocrit: difference between the two esters?
- No amplitude difference in stimulated erythropoiesis. Coviello 2008 demonstrated that the erythropoietic effect of testosterone is dose-dependent and independent of the ester used: the target is the hepatic and medullary androgen receptor that modulates hepcidin and EPO. Hematocrit monitoring at W0, W8 and W16 is identical for both: alert threshold 52%, action required (blood donation, dose reduction) at 54%. Thrombotic risk is linked to prolonged elevation, not to the ester.